Total raised
$2.7M
Last: Seed 2024-05
Stage
Seed
Founded
2020
Headcount
4
HQ
Yavne
Sector
Health Tech & Life Sciences
About
Genopore develops a cost-effective solution for whole-protein identification. The company's system, based on chip technology, is designed to be a single-molecule, high-sensitivity, and high-accuracy system that can handle large amounts of data. The goal is to offer early detection of cancer and other diseases, as well as potential uses in drug development, clinical settings, agriculture, food production, and academic research.
Funding history · 2 rounds · $2.7M total
2024-05
Seed
Undisclosed
2023-02
Seed
$2.7M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Semiconductors & ElectronicsSystem-on-a-chipSensingOpticArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProvidersLaboratoriesMedical Devices IndustryMedical Equipment
Business model
B2B
Tags
nanotechnologysemiconductorsmedical-devicessystem-on-chipoptical-sensorearly-detectiondiagnostics